Although this manuscript foregrounds estradiol + SERM co-therapy within the male BD context, the receptor systems it engages—ER-β and G protein–coupled estrogen receptor 1 (GPER1/GPR30)—function as conserved neuromodulatory hubs implicated across diagnostic categories. This evidence concerns the gene GPER1 and Behcet disease.